Asia's robotic revolution: Redefining affordable surgery and challenging da Vinci's legacy

The rapid rise of surgical robotics in Asia is revolutionizing the healthcare landscape, posing a significant challenge to the global dominance of Western systems like the da Vinci robot. Historically, the Da Vinci system has held a near-monopoly in robotic surgery, renowned for its precision, reliability, and widespread adoption. The Asia-Pacific market for surgical robots, valued at $1.4 billion in 2020, is projected to grow at a compound annual growth rate (CAGR) of 18.6%.
However, despite da Vinci’s advantages, its high installation and maintenance costs are prohibitive for many low- and middle-income countries in Asia. In response to this challenge, over the past decade, countries like China, Japan, South Korea, and India have made remarkable progress in developing homegrown surgical robots. These innovations are not only cost-effective but also specifically designed to address the unique healthcare needs of the region, including issues of accessibility, affordability, and disease burden. The emergence of these Asian-made surgical robots signals a broader trend of technological self-reliance and innovation, driven by robust government support and a rapidly growing medical device industry.
The present review explores the growth of robotic-assisted surgery in Asia, the impact of these new platforms on healthcare outcomes, and the global implications for competition in robotic surgery. By providing viable alternatives to da Vinci, Asia is poised to reshape the future of minimally invasive surgery, democratizing access to advanced surgical technologies across the region. The challenges facing the region, along with the future trajectory of this healthcare revolution, will also be discussed.